Philipp Lambach

2.8k citations
77 papers · 1.9k · 2 hit papers · h-index 24

Impact in

  • Health top 0.5%
    • Vaccine Coverage and Hesitancy
  • Toxicology top 2%
    • Pharmacovigilance and Adverse Drug Reactions

Papers in

  • Health 40
    • Vaccine Coverage and Hesitancy 40
  • Epidemiology 24
    • Influenza Virus Research Studies 21
Co-authors
Justin R. Ortiz (13 shared papers)Raymond C. W. Hutubessy (16 shared papers)Joachim Hombach (12 shared papers)Nathorn Chaiyakunapruk (6 shared papers)Kathleen Maletic Neuzil (5 shared papers)Punam Mangtani (1 shared paper)Janet A. Englund (1 shared paper)Robert Pless (1 shared paper)
Journals
Vaccine (41 papers)Vaccines (7 papers)Influenza and Other Respiratory Viruses (4 papers)Clinical Infectious Diseases (3 papers)Vaccine X (3 papers)
Partner nations
SwitzerlandUnited StatesUnited Kingdom

In The Last Decade

Philipp Lambach

71 papers receiving 1.8k citations

Philipp Lambach's Hit Papers

Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization 2024 · 279 citations
2790+1+2Years since publication50100150200250
What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

  1. 2024 The Lancet
  2. 2023 Vaccine

Peers

Philipp Lambach
Comparison fields: 5 of 98
  • Health 811
  • Toxicology 105
  • Epidemiology 541
  • Microbiology 97
  • Public Health, Environmental and Occupational Health 242
Replace John D. Grabenstein with:
John D. Grabenstein United States
Margaret A Burgess Australia
Mary Mason McCauley United States
PATRICK L. F. ZUBER Switzerland
Sandra W. Roush United States
Ann Lindstrand Sweden
Sara Boccalini Italy
Angela Bechini Italy
Donna MacKinnon‐Cameron Canada
W. A. Orenstein United States
Philipp Lambach relative to John D. Grabenstein United States John D. Grabenstein's profile →
Citations per field
00.5×2×3×4.3×
John D. Grabenstein · 1×
Citations per year

Countries citing papers authored by Philipp Lambach

Since Specialization
Citations

This map shows the geographic impact of Philipp Lambach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Lambach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Lambach more than expected).

Fields of papers citing papers by Philipp Lambach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Lambach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Lambach. The network helps show where Philipp Lambach may publish in the future.

Co-authors

The 25 scholars most cited alongside Philipp Lambach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philipp Lambach Line = papers co-authored together Philipp Lambach links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization
The Lancet ·Andrew James Shattock, Helen Johnson, So Yoon Sim, Austin Carter, Philipp Lambach, Raymond C. W. Hutubessy, Kimberly M. Thompson, Kamran Badizadegan
Hit paper breakdown →		2024279
2
Safety of immunization during pregnancy: A review of the evidence of selected inactivated and live attenuated vaccines
Vaccine ·Brigitte Keller‐Stanislawski, Janet A. Englund, Gagandeep Kang, Punam Mangtani, Kathleen Maletic Neuzil, Hanna Nohynek, Robert Pless, Philipp Lambach +1 other
2014172
3
A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization
Vaccine ·Justin R. Ortiz, Marc Perut, Laure B. Dumolard, Pushpa Ranjan Wijesinghe, Pernille Jorgensen, Alba María Ropero, Maria Carolina Danovaro-Holliday, James D. Heffelfinger
2016148
4
The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis
Journal of the American Pharmacists Association ·Lan My Le, Sajesh Kalkandi Veettil, Warittakorn Kategeaw, Raymond C. W. Hutubessy, Philipp Lambach, Nathorn Chaiyakunapruk +1 other
202288
5
Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030
Vaccine ·Austin Carter, William Msemburi, So Yoon Sim, Katy A. M. Gaythorpe, Philipp Lambach, Ann Lindstrand, Raymond C. W. Hutubessy
Hit paper breakdown →		202372
6
Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics – a systematic literature review
Influenza and Other Respiratory Viruses ·Siddhivinayak S. Hirve, Philipp Lambach, William John Paget, Katelijn Vandemaele, Julia Fitzner, Wenqing Zhang
201669
7
The faces of influenza vaccine recommendation: A Literature review of the determinants and barriers to health providers’ recommendation of influenza vaccine in pregnancy
Vaccine ·Kathleen F. Morales, Lisa Menning, Philipp Lambach
202044
8
Seasonal influenza vaccination policies in the 194 WHO Member States: The evolution of global influenza pandemic preparedness and the challenge of sustaining equitable vaccine access
Vaccine X ·Kathleen F. Morales, Laure B. Dumolard, Claudia Steulet, Alba Vilajeliu, Alba Álvarez, Ann C. Moen, Martin Friede, Philipp Lambach +1 other
202144
9
Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women
Vaccine ·Christine Elizabeth Jones, Flor M. Muñoz, Hans M. L. Spiegel, Ulrich Heininger, PATRICK L. F. ZUBER, Kathryn M. Edwards, Philipp Lambach, Pieter Neels
201643
10
Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions
Vaccine ·Flor M. Muñoz, Linda O'Neal Eckert, Mark A. Katz, Philipp Lambach, Justin R. Ortiz, Jorgen Bauwens, Jan Bonhoeffer
201542
11
Key considerations for successful implementation of maternal immunization programs in low and middle income countries
Human Vaccines & Immunotherapeutics ·Sushena Krishnaswamy, Philipp Lambach, Michelle Giles
201939
12
Seasonal influenza vaccination in middle-income countries: Assessment of immunization practices in Belarus, Morocco, and Thailand
Vaccine ·Carsten F. Mantel, Susan Y. Chu, Terri B. Hyde, Philipp Lambach
201939
13
Effective vaccine safety systems in all countries: A challenge for more equitable access to immunization
Vaccine ·Ananda Amarasinghe, STEVEN B. BLACK, Jan Bonhoeffer, Sandra Maria Deotti Carvalho, Alexander Dodoo, Juhani Eskola, Heidi Jane Larson, Sunheang Shin
201338
14
A rapid evidence appraisal of influenza vaccination in health workers: An important policy in an area of imperfect evidence
Vaccine X ·Dawn C. Jenkin, Hamid Mahgoub, Kathleen F. Morales, Philipp Lambach, Jonathan S. Nguyen‐Van‐Tam
201938
15
Considerations of strategies to provide influenza vaccine year round
Vaccine ·Philipp Lambach, Alba Álvarez, Siddhivinayak S. Hirve, Justin R. Ortiz, Joachim Hombach, Marcel F. Verweij, Laszlo Palkonyay, Michael Pfleiderer +1 other
201535
16
Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16–17, Berlin, Germany
Vaccine ·Thomas Cherian, Kathleen F. Morales, Carsten F. Mantel, Philipp Lambach, Salah Thabit Al Awaidy, Joseph Bresee, Supamit Chunsuttiwat, Daouda Coulibaly
201934
17
A systematic review of adverse events following immunization during pregnancy and the newborn period
Vaccine ·T. Roice Fulton, Jan Bonhoeffer, Justin R. Ortiz, Philipp Lambach, Saad B. Omer +1 other
201532
18
Association Between Pandemic Influenza A(H1N1) Vaccination in Pregnancy and Early Childhood Morbidity in Offspring
Archives of Pediatrics and Adolescent Medicine ·Anders Peter Hviid, Henrik Svanström, Ditte Mølgaard‐Nielsen, Philipp Lambach
201632
19
Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey
Vaccine ·Alison M. Kraigsley, Kristine A. Moore, Amanda Bolster, Maya Peters, Dominique Richardson, Meredith Arpey, Michelle Sonnenberger, Margaret McCarron
202132
20
WHO guide on the economic evaluation of influenza vaccination
Influenza and Other Respiratory Viruses ·Anthony T. Newall, Nathorn Chaiyakunapruk, Philipp Lambach, Raymond C. W. Hutubessy
201730

About Philipp Lambach

Philipp Lambach is a scholar working on Health, Epidemiology, Toxicology, Economics and Econometrics and Public Health, Environmental and Occupational Health, having authored 77 papers that have together received 1.9k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (40 papers), Influenza Virus Research Studies (21 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers), Pharmacovigilance and Adverse Drug Reactions (9 papers), Neonatal and Maternal Infections (6 papers), Global Maternal and Child Health (6 papers), Pharmaceutical Economics and Policy (4 papers) and Bacterial Infections and Vaccines (4 papers). The work is most often cited by research in Health (811 citations), Toxicology (105 citations), Epidemiology (541 citations), Microbiology (97 citations) and Public Health, Environmental and Occupational Health (242 citations). Philipp Lambach has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Justin R. Ortiz, Raymond C. W. Hutubessy, Joachim Hombach, Nathorn Chaiyakunapruk, Kathleen Maletic Neuzil, Punam Mangtani, Janet A. Englund, Robert Pless, Brigitte Keller‐Stanislawski and Hanna Nohynek. Their work appears in journals such as Vaccine, Vaccines, Influenza and Other Respiratory Viruses, Clinical Infectious Diseases and Vaccine X.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John D. GrabensteinBreakdown of academic impact, for papers by Margaret A BurgessBreakdown of academic impact, for papers by Mary Mason McCauleyBreakdown of academic impact, for papers by PATRICK L. F. ZUBERBreakdown of academic impact, for papers by Sandra W. RoushBreakdown of academic impact, for papers by Ann LindstrandBreakdown of academic impact, for papers by Sara BoccaliniBreakdown of academic impact, for papers by Angela BechiniBreakdown of academic impact, for papers by Donna MacKinnon‐CameronBreakdown of academic impact, for papers by W. A. Orenstein